Risks of colorectal and extracolonic cancers following colorectal cancer: a systematic review and meta-analysis
JNCI Cancer Spectrum · 30.04.2025 · 9 (3)
DOI: 10.1093/jncics/pkaf031 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 20.03.2025. Verfasst von Ye Kyaw Aung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoplasms, Second Primary, Cancer Survivors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Melbourne Research Scholarship, University of Melbourne.
Abstract (Originalsprache)
Background
Colorectal cancer survivors face increased risks of developing new primary cancers in colorectum and other anatomical sites. This systematic review aimed to estimate primary colorectal and extracolonic cancers risks following colorectal cancer.
Methods
Peer-reviewed articles published before January 2025 were screened across 4 databases to identify studies using population cancer registry reporting standardized incidence ratios (SIRs) of primary cancers following colorectal cancer, compared with the general population. A meta-analysis was conducted to summarize the SIRs, and age-specific cumulative risks of primary cancers following colorectal cancer were estimated using the summarized SIRs and age-, sex-, calendar-, region-, and cancer-specific incidence data.
Results
Of 8254 articles identified, 57 were included in meta-analysis. The pooled SIRs (95% confidence interval) for any primary cancer, extracolonic cancer and colorectal cancer were 1.13 (1.06 to 1.20), 1.10 (1.03 to 1.17), and 1.55 (1.33 to 1.77), respectively. Increased risks were also observed for primary cancers of small intestine, ovary, uterus, testes, kidney, female breast, thyroid, and prostate overall, as well as for lung and urinary bladder cancer in recent studies. The cumulative risks of any primary cancer, extracolonic cancer, and colorectal cancer to age 75 years were 38.5%, 31.6%, and 8.24% in Australasia; 33.8%, 30.9%, and 4.77% in North America; 27.4%, 25.6%, and 8.01% in East Asia; and 33.4%, 28.8%, and 4.68% in Europe.
Conclusion
Colorectal cancer survivors have an increased risk of subsequent primary cancers, both extracolonic and colorectal, when compared with the general population. These findings underscore the necessity for tailored surveillance and prevention strategies to effectively identify and manage subsequent primary cancers in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia.
- Familial Cancer Centre, Genetic Medicine, Royal Melbourne Hospital, Parkville, VIC, Australia.
ORCID-Profile: Ye Kyaw Aung, Ye Zhang, Mark A Jenkins, Aung Ko Win
Förderung
- National Health and Medical Research Council
- Melbourne Research Scholarship
- University of Melbourne
- China Scholarship Council-University of Melbourne
- NHMRC Emerging Leadership
- China Scholarship Council—University of Melbourne
Zitieren
APA
Aung, Y. K., Zhang, Y., Jenkins, M. A., & Win, A. K. (2025). Risks of colorectal and extracolonic cancers following colorectal cancer: a systematic review and meta-analysis. JNCI Cancer Spectrum, 9(3). https://doi.org/10.1093/jncics/pkaf031
Vancouver
Aung YK, Zhang Y, Jenkins MA, Win AK. Risks of colorectal and extracolonic cancers following colorectal cancer: a systematic review and meta-analysis. JNCI Cancer Spectrum. 2025;9(3). doi:10.1093/jncics/pkaf031
BibTeX
@article{Aung2025,
author = {Aung, Ye Kyaw and Zhang, Ye and Jenkins, Mark A and Win, Aung Ko},
title = {Risks of colorectal and extracolonic cancers following colorectal cancer: a systematic review and meta-analysis},
journal = {JNCI Cancer Spectrum},
year = {2025},
volume = {9},
number = {3},
doi = {10.1093/jncics/pkaf031}
}
EUVIMED